ID   PTPRN_MOUSE             Reviewed;         979 AA.
AC   Q60673; E9Q746; Q62129;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   07-APR-2021, entry version 151.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase-like N;
DE            Short=R-PTP-N;
DE   AltName: Full=PTP IA-2 {ECO:0000305};
DE   Contains:
DE     RecName: Full=ICA512-N-terminal fragment;
DE              Short=ICA512-NTF;
DE   Contains:
DE     RecName: Full=ICA512-transmembrane fragment;
DE              Short=ICA512-TMF;
DE   Contains:
DE     RecName: Full=ICA512-cleaved cytosolic fragment;
DE              Short=ICA512-CCF;
DE   Flags: Precursor;
GN   Name=Ptprn; Synonyms=Ptp35;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], LACK OF FUNCTION AS PROTEIN TYROSINE
RP   PHOSPHATASE, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7980563; DOI=10.1006/bbrc.1994.2549;
RA   Lu J., Notkins A.L., Lan M.S.;
RT   "Isolation, sequence and expression of a novel mouse brain cDNA, mIA-2, and
RT   its relatedness to members of the protein tyrosine phosphatase family.";
RL   Biochem. Biophys. Res. Commun. 204:930-936(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Swiss Webster; TISSUE=Fibroblast;
RX   PubMed=8526904; DOI=10.1006/bbrc.1995.2758;
RA   Magistrelli G., Covini N., Mosca M., Lippoli G., Isacchi A.;
RT   "Expression of PTP35, the murine homologue of the protein tyrosine
RT   phosphatase-related sequence IA-2, is regulated during cell growth and
RT   stimulated by mitogens in 3T3 fibroblasts.";
RL   Biochem. Biophys. Res. Commun. 217:154-161(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   LACK OF FUNCTION AS PROTEIN TYROSINE PHOSPHATASE, AND MUTAGENESIS OF
RP   ALA-877 AND ASP-911.
RX   PubMed=8878556; DOI=10.1006/bbrc.1996.1549;
RA   Magistrelli G., Toma S., Isacchi A.;
RT   "Substitution of two variant residues in the protein tyrosine phosphatase-
RT   like PTP35/IA-2 sequence reconstitutes catalytic activity.";
RL   Biochem. Biophys. Res. Commun. 227:581-588(1996).
RN   [5]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12031972; DOI=10.2337/diabetes.51.6.1842;
RA   Saeki K., Zhu M., Kubosaki A., Xie J., Lan M.S., Notkins A.L.;
RT   "Targeted disruption of the protein tyrosine phosphatase-like molecule IA-2
RT   results in alterations in glucose tolerance tests and insulin secretion.";
RL   Diabetes 51:1842-1850(2002).
RN   [6]
RP   FUNCTION, SELF-ASSOCIATION, AND INTERACTION WITH PTPRN2; PTPRA AND PTPRE.
RX   PubMed=12364328; DOI=10.1074/jbc.m208228200;
RA   Gross S., Blanchetot C., Schepens J., Albet S., Lammers R., den Hertog J.,
RA   Hendriks W.;
RT   "Multimerization of the protein-tyrosine phosphatase (PTP)-like insulin-
RT   dependent diabetes mellitus autoantigens IA-2 and IA-2beta with receptor
RT   PTPs (RPTPs). Inhibition of RPTPalpha enzymatic activity.";
RL   J. Biol. Chem. 277:48139-48145(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=15939893; DOI=10.1073/pnas.0408887102;
RA   Harashima S., Clark A., Christie M.R., Notkins A.L.;
RT   "The dense core transmembrane vesicle protein IA-2 is a regulator of
RT   vesicle number and insulin secretion.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:8704-8709(2005).
RN   [8]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16269463; DOI=10.1210/en.2005-0638;
RA   Kubosaki A., Nakamura S., Clark A., Morris J.F., Notkins A.L.;
RT   "Disruption of the transmembrane dense core vesicle proteins IA-2 and IA-
RT   2beta causes female infertility.";
RL   Endocrinology 147:811-815(2006).
RN   [9]
RP   FUNCTION.
RX   PubMed=18178618; DOI=10.1073/pnas.0710931105;
RA   Mziaut H., Kersting S., Knoch K.P., Fan W.H., Trajkovski M., Erdmann K.,
RA   Bergert H., Ehehalt F., Saeger H.D., Solimena M.;
RT   "ICA512 signaling enhances pancreatic beta-cell proliferation by regulating
RT   cyclins D through STATs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:674-679(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=19019914; DOI=10.1152/ajprenal.90543.2008;
RA   Kim S.M., Theilig F., Qin Y., Cai T., Mizel D., Faulhaber-Walter R.,
RA   Hirai H., Bachmann S., Briggs J.P., Notkins A.L., Schnermann J.;
RT   "Dense-core vesicle proteins IA-2 and IA-2{beta} affect renin synthesis and
RT   secretion through the {beta}-adrenergic pathway.";
RL   Am. J. Physiol. 296:F382-F389(2009).
RN   [11]
RP   DISRUPTION PHENOTYPE, FUNCTION, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=19361477; DOI=10.1016/j.neuroscience.2009.01.022;
RA   Nishimura T., Kubosaki A., Ito Y., Notkins A.L.;
RT   "Disturbances in the secretion of neurotransmitters in IA-2/IA-2beta null
RT   mice: changes in behavior, learning and lifespan.";
RL   Neuroscience 159:427-437(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307 AND SER-308, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [13]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=21732083; DOI=10.1007/s00125-011-2221-6;
RA   Cai T., Hirai H., Zhang G., Zhang M., Takahashi N., Kasai H., Satin L.S.,
RA   Leapman R.D., Notkins A.L.;
RT   "Deletion of Ia-2 and/or Ia-2beta in mice decreases insulin secretion by
RT   reducing the number of dense core vesicles.";
RL   Diabetologia 54:2347-2357(2011).
CC   -!- FUNCTION: Plays a role in vesicle-mediated secretory processes
CC       (PubMed:21732083). Required for normal accumulation of secretory
CC       vesicles in hippocampus, pituitary and pancreatic islets. Required for
CC       the accumulation of normal levels of insulin-containing vesicles and
CC       preventing their degradation (PubMed:15939893, PubMed:21732083). Plays
CC       a role in insulin secretion in response to glucose stimuli
CC       (PubMed:12031972, PubMed:21732083). Required for normal accumulation of
CC       the neurotransmitters norepinephrine, dopamine and serotonin in the
CC       brain (PubMed:16269463). In females, but not in males, required for
CC       normal accumulation and secretion of pituitary hormones, such as
CC       luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
CC       (PubMed:16269463). Seems to lack intrinsic enzyme activity
CC       (PubMed:7980563, PubMed:8878556). Required to maintain normal levels of
CC       renin expression and renin release (PubMed:19019914). May regulate
CC       catalytic active protein-tyrosine phosphatases such as PTPRA through
CC       dimerization (PubMed:12364328). {ECO:0000250|UniProtKB:Q16849,
CC       ECO:0000269|PubMed:12031972, ECO:0000269|PubMed:12364328,
CC       ECO:0000269|PubMed:15939893, ECO:0000269|PubMed:19019914,
CC       ECO:0000269|PubMed:7980563, ECO:0000269|PubMed:8878556}.
CC   -!- FUNCTION: [ICA512-transmembrane fragment]: ICA512-TMF regulates
CC       dynamics and exocytosis of insulin secretory granules (SGs); binding of
CC       ICA512-TMF to SNTB2/beta-2-syntrophin is proposed to restrain SGs
CC       mobility and exocytosis by tethering them to the actin cytoskeleton
CC       depending on UTRN; the function is inhibited by cytoplasmic ICA512-CFF
CC       dimerizing with ICA512-TMF and displacing SNTB2 (By similarity).
CC       {ECO:0000250|UniProtKB:Q16849}.
CC   -!- FUNCTION: [ICA512-cleaved cytosolic fragment]: ICA512-CCF translocated
CC       to the nucleus promotes expression of insulin and other granule-related
CC       genes; the function implicates binding to and regulating activity of
CC       STAT5B probably by preventing its dephosphorylation and potentially by
CC       inducing its sumoylation by recruiting PIAS4 (By similarity). Enhances
CC       pancreatic beta-cell proliferation by converging with signaling by
CC       STAT5B and STAT3 (PubMed:18178618). ICA512-CCF located in the cytoplasm
CC       regulates dynamics and exocytosis of insulin secretory granules (SGs)
CC       by dimerizing with ICA512-TMF and displacing SNTB2 thus enhancing SGs
CC       mobility and exocytosis (By similarity). {ECO:0000250|UniProtKB:Q16849,
CC       ECO:0000269|PubMed:18178618}.
CC   -!- SUBUNIT: Homodimer; shown for the unprocessed protein (proICA512) in
CC       the endoplasmic reticulum and resolved during protein maturation as
CC       ICA512-TMF seems to be predominantly monomeric in secretory granules;
CC       however, ICA512-CCF interacts with ICA512-TMF disrupting the ICA512-
CC       TMF:SNTB2 complex. The isolated lumenal RESP18 homology domain has been
CC       shown to form disulfide-linked homooligomers. Interacts (via
CC       cytoplasmic domain) with phosphorylated SNTB2; this protects PTPRN
CC       against cleavage by CAPN1 to produce ICA512-CCF. Dephosphorylation of
CC       SNTB2 upon insulin stimulation disrupts the interaction and results in
CC       PTPRN cleavage. Interacts with SNX19. ICA512-CCF interacts with PIAS4;
CC       in the nucleus. Interacts with STAT5B (phosphorylated); down-regulated
CC       by ICA512-CCF sumoylation; ICA512-CCF prevents STAT5B
CC       dephosphorylation; ICA512-CCF mediates interaction of STAT5B with
CC       PIAS4. Interacts (via RESP18 homology domain) with insulin and
CC       proinsulin (By similarity). Interacts with PTPRN2, PTPRA and PTPRE
CC       (PubMed:12364328). {ECO:0000250|UniProtKB:Q16849,
CC       ECO:0000269|PubMed:12364328}.
CC   -!- INTERACTION:
CC       Q60673; P18052: Ptpra; NbExp=3; IntAct=EBI-8328895, EBI-6597520;
CC       Q60673; P80560: Ptprn2; NbExp=4; IntAct=EBI-8328895, EBI-8538944;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:Q63259}; Single-
CC       pass type I membrane protein {ECO:0000250|UniProtKB:Q63259}.
CC       Cytoplasmic vesicle, secretory vesicle membrane
CC       {ECO:0000269|PubMed:19361477}; Single-pass type I membrane protein
CC       {ECO:0000305}. Perikaryon {ECO:0000250|UniProtKB:Q63259}. Cell
CC       projection, axon {ECO:0000250|UniProtKB:Q63259}. Cell junction, synapse
CC       {ECO:0000250|UniProtKB:Q63259}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q63259}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q63259}. Endosome
CC       {ECO:0000250|UniProtKB:Q63259}. Note=Detected on neuronal secretory
CC       vesicles, but not on synaptic vesicles. Colocalizes with insulin-
CC       containing secretory granules. Primarily detected on secretory vesicle
CC       membranes. Transiently found at the cell membrane, when secretory
CC       vesicles fuse with the cell membrane to release their cargo. Is then
CC       endocytosed and recycled to secretory vesicles via the Golgi apparatus
CC       membranes. {ECO:0000250|UniProtKB:Q63259}.
CC   -!- SUBCELLULAR LOCATION: [ICA512-transmembrane fragment]: Cytoplasmic
CC       vesicle, secretory vesicle membrane {ECO:0000250|UniProtKB:Q63259}.
CC   -!- SUBCELLULAR LOCATION: [ICA512-cleaved cytosolic fragment]: Nucleus
CC       {ECO:0000250|UniProtKB:Q16849}.
CC   -!- TISSUE SPECIFICITY: Detected in pituitary (PubMed:16269463). Detected
CC       in brain (at protein level) (PubMed:12031972, PubMed:16269463,
CC       PubMed:19361477). Detected in brain (PubMed:7980563, PubMed:12031972).
CC       Weakly expressed in the colon, intestine, stomach and pancreas
CC       (PubMed:7980563). {ECO:0000269|PubMed:12031972,
CC       ECO:0000269|PubMed:16269463, ECO:0000269|PubMed:19361477,
CC       ECO:0000269|PubMed:7980563}.
CC   -!- DOMAIN: The RESP18 homology domain is sufficient for targeting
CC       proICA512 to secretory granules. {ECO:0000250|UniProtKB:Q16849}.
CC   -!- PTM: Subject to proteolytic cleavage at multiple sites. Subject to
CC       cleavage on a pair of basic residues. On exocytosis of secretory
CC       granules in pancreatic beta-cells ICA512-TMF is transiently inserted in
CC       the plasma-membrane and cleaved by mu-type calpain CPN1 to yield
CC       ICA512-CCF. {ECO:0000250|UniProtKB:P56722,
CC       ECO:0000250|UniProtKB:Q16849, ECO:0000250|UniProtKB:Q63259}.
CC   -!- PTM: O-glycosylated. {ECO:0000250|UniProtKB:Q16849}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q16849}.
CC   -!- PTM: Sumoylated at two sites including Lys-754. Sumoylation decreases
CC       interaction with STAT5. {ECO:0000250|UniProtKB:Q16849}.
CC   -!- DISRUPTION PHENOTYPE: Mice are born at the expected Mendelian rate,
CC       appear healthy and normal, but show impaired glucose tolerance and
CC       impaired insulin secretion in response to glucose (PubMed:12031972).
CC       Pancreatic islets from mice lacking both Ptprn and Ptprn2 contain
CC       decreased numbers of insulin-containing vesicles and show a further
CC       decrease in insulin secretion after glucose stimuli (PubMed:21732083).
CC       Mice lacking both Ptprn and Ptprn2 appear normal, but have lower levels
CC       of the neurotransmitters norepinephrine, dopamine and serotonin in the
CC       brain. Likewise, they have decreased numbers of synaptic vesicles in
CC       the hippocampus and show decreased neurotransmitter release after K(+)
CC       stimulation; basal levels of neurotransmitter release are unaffected.
CC       They show increased anxiety-like behavior with strongly decreased
CC       exploratory activity and rearing. Besides, they show defects in
CC       remembering conditioned learning. With increasing age, mutant mice
CC       develop a tendency to suffer seizures and display a reduced life span;
CC       roughly half of the mutant mice are dead after 40 weeks
CC       (PubMed:19361477). The majority of female mice deficient in both Ptprn
CC       and Ptprn2 are infertile or have small litters, due to abnormalities of
CC       the estrous cycle and absence of corpora lutea. These defects are due
CC       to decreased levels of luteinizing hormone and follicle-stimulating
CC       hormone (FSH) in the pituitary and decreased levels of luteinizing
CC       hormone (LH) in the blood plasma. In contrast, male mice lacking both
CC       Ptprn and Ptprn2 display normal hormone levels and normal fertility
CC       (PubMed:16269463). {ECO:0000269|PubMed:12031972,
CC       ECO:0000269|PubMed:16269463}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 8 subfamily. {ECO:0000305}.
CC   -!- CAUTION: Does not possess catalytic activity due to replacement of
CC       highly conserved residues in tyrosine-protein phosphatase domain.
CC       {ECO:0000305|PubMed:8878556}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA52453.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U11812; AAA52102.1; -; mRNA.
DR   EMBL; X74438; CAA52453.1; ALT_INIT; mRNA.
DR   EMBL; AC166150; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; I48721; I48721.
DR   PIR; JC2349; JC2349.
DR   SMR; Q60673; -.
DR   IntAct; Q60673; 5.
DR   MINT; Q60673; -.
DR   STRING; 10090.ENSMUSP00000027404; -.
DR   GlyConnect; 2672; 1 N-Linked glycan (1 site).
DR   GlyGen; Q60673; 2 sites.
DR   iPTMnet; Q60673; -.
DR   PhosphoSitePlus; Q60673; -.
DR   MaxQB; Q60673; -.
DR   PaxDb; Q60673; -.
DR   PRIDE; Q60673; -.
DR   ProteomicsDB; 301948; -.
DR   UCSC; uc011wnn.1; mouse.
DR   MGI; MGI:102765; Ptprn.
DR   eggNOG; KOG0793; Eukaryota.
DR   InParanoid; Q60673; -.
DR   ChiTaRS; Ptprn; mouse.
DR   PRO; PR:Q60673; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; Q60673; protein.
DR   GO; GO:0043679; C:axon terminus; ISS:UniProtKB.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0043025; C:neuronal cell body; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0043204; C:perikaryon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030141; C:secretory granule; ISS:UniProtKB.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0030658; C:transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0051020; F:GTPase binding; ISO:MGI.
DR   GO; GO:0030507; F:spectrin binding; ISO:MGI.
DR   GO; GO:0008134; F:transcription factor binding; ISO:MGI.
DR   GO; GO:0044389; F:ubiquitin-like protein ligase binding; ISO:MGI.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISO:MGI.
DR   GO; GO:1990502; P:dense core granule maturation; ISO:MGI.
DR   GO; GO:0030073; P:insulin secretion; ISO:MGI.
DR   GO; GO:0035773; P:insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   GO; GO:0001553; P:luteinization; IMP:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; IEA:GOC.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:1904692; P:positive regulation of type B pancreatic cell proliferation; IMP:UniProtKB.
DR   GO; GO:0000302; P:response to reactive oxygen species; ISS:UniProtKB.
DR   Gene3D; 3.30.70.2470; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR033522; IA-2/IA-2_beta.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR021613; Receptor_IA-2_dom.
DR   InterPro; IPR038112; Receptor_IA-2_ectodomain_sf.
DR   InterPro; IPR029403; RESP18_dom.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   PANTHER; PTHR46106; PTHR46106; 1.
DR   Pfam; PF11548; Receptor_IA-2; 1.
DR   Pfam; PF14948; RESP18; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Cytoplasmic vesicle;
KW   Disulfide bond; Endosome; Glycoprotein; Isopeptide bond; Membrane; Nucleus;
KW   Phosphoprotein; Receptor; Reference proteome; Signal; Synapse;
KW   Transcription; Transcription regulation; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..37
FT                   /evidence="ECO:0000250"
FT   CHAIN           38..979
FT                   /note="Receptor-type tyrosine-protein phosphatase-like N"
FT                   /id="PRO_0000025452"
FT   CHAIN           38..448
FT                   /note="ICA512-N-terminal fragment"
FT                   /evidence="ECO:0000250|UniProtKB:P56722,
FT                   ECO:0000250|UniProtKB:Q16849"
FT                   /id="PRO_0000438082"
FT   CHAIN           449..979
FT                   /note="ICA512-transmembrane fragment"
FT                   /evidence="ECO:0000250|UniProtKB:P56722,
FT                   ECO:0000250|UniProtKB:Q16849"
FT                   /id="PRO_0000438083"
FT   CHAIN           659..979
FT                   /note="ICA512-cleaved cytosolic fragment"
FT                   /evidence="ECO:0000250|UniProtKB:Q16849"
FT                   /id="PRO_0000438084"
FT   TOPO_DOM        38..575
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        576..600
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        601..979
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          709..969
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          38..134
FT                   /note="RESP18 homology domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q16849"
FT   REGION          449..575
FT                   /note="Sufficient for dimerization of proICA512"
FT                   /evidence="ECO:0000250|UniProtKB:Q16849"
FT   REGION          601..732
FT                   /note="Sufficient for dimerization of proICA512"
FT                   /evidence="ECO:0000250|UniProtKB:P80560"
FT   SITE            448..449
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:P56722"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         308
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   CARBOHYD        506
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        524
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        43
FT                   /note="Interchain (with C-43 or C-50); in multimeric form"
FT                   /evidence="ECO:0000250|UniProtKB:Q16849"
FT   DISULFID        50
FT                   /note="Interchain (with C-43 or C-50); in multimeric form"
FT                   /evidence="ECO:0000250|UniProtKB:Q16849"
FT   DISULFID        56..65
FT                   /evidence="ECO:0000250|UniProtKB:Q16849"
FT   CROSSLNK        754
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250|UniProtKB:Q16849"
FT   MUTAGEN         877
FT                   /note="A->D: No effect on dephosphorylating activity;
FT                   increased the dephosphorylating efficiency; when associated
FT                   with 911-A."
FT                   /evidence="ECO:0000269|PubMed:8878556"
FT   MUTAGEN         911
FT                   /note="D->A: Confers dephosphorylating activity; increased
FT                   the dephosphorylating efficiency; when associated with 877-
FT                   D."
FT                   /evidence="ECO:0000269|PubMed:8878556"
FT   CONFLICT        166..169
FT                   /note="RSWG -> GDGAGA (in Ref. 2; CAA52453)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        363
FT                   /note="L -> M (in Ref. 1; AAA52102)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        615
FT                   /note="L -> V (in Ref. 2; CAA52453)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        675
FT                   /note="T -> S (in Ref. 1; AAA52102)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        859
FT                   /note="L -> V (in Ref. 2; CAA52453)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   979 AA;  106083 MW;  AA3A7E126A3C5F3D CRC64;
     MRRPRRPGGS GGSGGSGGLR LLVCLLLLSG RPGGCSAISA HGCLFDRRLC SHLEVCIQDG
     LFGQCQAGVG QARPLLQVTS PVLQRLQGVL RQLMSQGLSW HDDLTQHVIS QEMERIPRLR
     PPEPHPRDRS GLVPRKPGPA GELLTQGNPT GSSPAAQGFP RPAGGRSWGG SPLSSLQAEL
     LPPLLEHLLM PPQPPHPALT YEPALLQPYL FHQFGSRDGS RGSESSSGVV GVGHLSKAEG
     PALFSRSASK AILGTHSGHS FGDLTGPSPA QLFQDSGLLY MAQELPVPGR ARAPRLPENG
     GNRAEDSSEG HEEEVLGGRG EKSPPQAAQP ELSLQRLTAV LAGYGVELRQ LTPEQFSTLL
     TLLQLLPKGT GRNLEGAVNV GGADVKKTIQ QMQRGDPAEA LPPTPSLPGY LTASPASSEV
     QQVLSPGFPE PPHTPSPLGS SSVLLEKKSP LGQSQPTVVG RPSARPSAEE YGYIVTDQKP
     LSLVAGVRLL EILAEHVHMS SGSFINISVV GPAVTFRIRH NEQNLSLADV TQQAGLVKSE
     LEAQTGLQIL QTGVGQREEA AEVLPRQAHG ISPMRSVLLT LVALAGVAGL LVALAVALCM
     RHHSRQRDKE RLAALGPEGA HGDTTFEYQD LCRQHMATKS LFNRAEGQPE PSRVSSVSSQ
     FSDAAQASPS SHSSTPSWCE EPAQANMDIS TGHMILAYME DHLRNRDRLA KEWQALCAYQ
     AEPNTCAAAQ DESNIKKNRH PDFLPYDHAR IKLKVESSPS RSDYINASPI IEHDPRMPAY
     IATQGPLSHT IADFWQMVWE SGCTVIVMLT PLVEDGVKQC DRYWPDEGSS LYHVYEVNLV
     SEHIWCEDFL VRSFYLKNLQ TQETRTLTQF HFLSWPAEGT PASTRPLLDF RRKVNKCYRG
     RSCPIIVHCS DGAGRTGTYI LIDMVLNRMA KGVKEIDIAA TLEHVRDQRP GLVRSKDQFE
     FALTAVAEEV NAILKALPQ
//
